These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31088238)

  • 1. A coming of age for immune checkpoint inhibitors in cancer.
    Nipp RD; Gainor JF
    Immunotherapy; 2019 Jun; 11(8):647-650. PubMed ID: 31088238
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytotoxic Agents and Immune Checkpoint Inhibitors].
    Kawazoe A; Shitara K
    Gan To Kagaku Ryoho; 2017 Sep; 44(9):717-721. PubMed ID: 28912395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy comes of age: Immune aging & checkpoint inhibitors.
    Elias R; Karantanos T; Sira E; Hartshorn KL
    J Geriatr Oncol; 2017 May; 8(3):229-235. PubMed ID: 28223073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do immune checkpoint inhibitors increase sensitivity to salvage chemotherapy?
    Saleh K; Khalifeh-Saleh N; Kourie HR; Nasr F; Chahine G
    Immunotherapy; 2018 Mar; 10(3):163-165. PubMed ID: 29370724
    [No Abstract]   [Full Text] [Related]  

  • 5. [Benefits of combining chemotherapy with immuno- oncology therapies or "Is it true that chemotherapy destroys the immune system?"].
    Kocsis J
    Magy Onkol; 2019 Sep; 63(3):202-207. PubMed ID: 31533140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Administration of Immune Checkpoint Inhibitor for Cancer except for Melanoma and Lung Cancer].
    Takeda T; Hattori N; Takeda T; Noda T; Takeda H
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1271-1273. PubMed ID: 27760957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosenescence and cancer.
    Pawelec G
    Biogerontology; 2017 Aug; 18(4):717-721. PubMed ID: 28220304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Checkpoint Inhibitors: Basics and Challenges.
    Li B; Chan HL; Chen P
    Curr Med Chem; 2019; 26(17):3009-3025. PubMed ID: 28782469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough.
    Bersanelli M; Buti S; De Giorgi U; Di Maio M; Giannarelli D; Pignata S; Banna GL
    Crit Rev Oncol Hematol; 2019 Jul; 139():87-90. PubMed ID: 31112887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination Therapy of Immune Checkpoint Inhibitors].
    Kitano S
    Gan To Kagaku Ryoho; 2017 Sep; 44(9):727-732. PubMed ID: 28912397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the Guest Editor: Immune Checkpoint Therapy as a Weapon Against Cancer.
    Sharma P
    Cancer J; 2016; 22(2):67. PubMed ID: 27111899
    [No Abstract]   [Full Text] [Related]  

  • 12. PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses.
    Medina PJ; Adams VR
    Pharmacotherapy; 2016 Mar; 36(3):317-34. PubMed ID: 26822752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.
    Conforti F; Pala L; Bagnardi V; De Pas T; Martinetti M; Viale G; Gelber RD; Goldhirsch A
    Lancet Oncol; 2018 Jun; 19(6):737-746. PubMed ID: 29778737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of therapeutic monoclonal antibodies: implications for cancer therapy including immuno-checkpoint inhibitors.
    Demlova R; Valík D; Obermannova R; ZdraŽilová-Dubská L
    Physiol Res; 2016 Dec; 65(Suppl 4):S455-S462. PubMed ID: 28006927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapeutic properties of chemotherapy.
    Fournier C; Rivera Vargas T; Martin T; Melis A; Apetoh L
    Curr Opin Pharmacol; 2017 Aug; 35():83-88. PubMed ID: 28551360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors.
    Gentzler R; Hall R; Kunk PR; Gaughan E; Dillon P; Slingluff CL; Rahma OE
    Immunotherapy; 2016 May; 8(5):583-600. PubMed ID: 27140411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune modulation in cancer with antibodies.
    Page DB; Postow MA; Callahan MK; Allison JP; Wolchok JD
    Annu Rev Med; 2014; 65():185-202. PubMed ID: 24188664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Immunotherapy in Older Patients.
    Marrone KA; Forde PM
    Cancer J; 2017; 23(4):219-222. PubMed ID: 28731944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating Pembrolizumab to Clinical Practice: Speak Immunology and Learn Fast!
    van Elsas A; van Eenennaam H; Haanen JB
    Clin Cancer Res; 2015 Oct; 21(19):4251-3. PubMed ID: 26169966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin Reactions to Immune Checkpoint Inhibitors.
    Patel AB; Pacha O
    Adv Exp Med Biol; 2017; 995():175-184. PubMed ID: 28321818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.